Download the presentation by entering your information below. 

Learn about clinical research partnerships with PPD

Meet with our colleagues at PPD, part of Thermo Fisher Scientific, to learn more about participating in oncology clinical trials. 

Hear from the experts

Watch these on-demand webinars

Using rapid NGS testing for trial assignment in the NCI precision medicine initiative in AML and MDS (myeloMATCH)

Learn how the NCI myeloMATCH trial is using rapid NGS testing with the Ion Torrent Genexus System to help enable study enrollment within 72 hours for newly diagnosed AML and MDS patients.

NCI has validated Genexus for investigational use within the MyeloMatch study. Genexus is currently available in the North America for research use only. Not for use in diagnostic procedures.

Jerald Radich, MD
Professor, University of Washington School of Medicine, Member Clinical Research Division Kurt Enslein
Endowed Chair
Fred Hutchinson Cancer Research Center

On-Demand Webinars

Rapid NGS for genomic profiling of
myeloid malignancies

In this workshop, see how rapid NGS is helping to facilitate swift patient enrollment into a clinical trial aiming to investigate the effectiveness of various therapeutic agents based on genetic testing results.

Also, learn how NGS technology is advancing measurable residual disease (MRD) analysis by detecting low‑frequency variants with high sensitivity across a broad number of genes simultaneously.

Cecilia Yeung, MD
Associate Professor
Fred Hutchinson Cancer Center
Medical Director,
Fred Hutch CLIA laboratories

View Recent Posters

Keep up with latest research involving NGS in hemato-oncology

ASH 2023 Scientific Poster: Rapid Clinical Mutation Screening for AML Using the Genexus Platform

See recent performance data for the NCI Myeloid Assay v2, showing high specificity, sensitivity, accuracy, and reproducibility (inter-lab and intra-lab) with sequencing results generated within 48 hours of assay initiation². Read Abstract

> View Poster

ASXL1p.G646Wfs*12 Detection Enabled and Integrated into a Rapid Automated Myeloid Variant Profiling Solution on Ion Torrent NGS Genexus System

Automated Nucleic Acid Purification on Ion Torrent™ Genexus™ to Support Variant Detection in Research of Myeloid Malignancies

Explore our full hemato-oncology research product portfolio

Explore The Genexus System

Experience our new interactive virtual demo

One complete NGS system

The Ion Torrent™ Genexus™ System is the only turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as a single day.*

Thinking about how the Genexus System works and how it could fit into your lab?

In our virtual laboratory environment powered by augmented reality (AR) technology, you can see:

• How the Ion Torrent™ Genexus™ Integrated Sequencer and Genexus™ Purification System fit into your space
• Each step of the NGS workflow, including purification, sequencing, and analysis
• Sample types and applications supported by the Genexus System

Literature

For Research Use Only.  Not for use in diagnostic procedures.

*Processing times for individual sample types vary

(58434 1124)